• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺毒症外科治疗中若干预后因素的评估

An evaluation of several prognostic factors in the surgical treatment for thyrotoxicosis.

作者信息

Makiuchi M, Miyakawa M, Sugenoya A, Furihata R

出版信息

Surg Gynecol Obstet. 1981 May;152(5):639-41.

PMID:7221848
Abstract

A follow-up survey of 447 patients who had undergone a subtotal thyroidectomy was carried out. In this study, 433 patients were observed, and the follow-up period ranged from one year to ten years. The incidence postoperatively of a recurrence and hypothyroidism was 9.6 and 2.3 per cent, respectively. Transient subclinical hypothyroidism was observed in most patients within three to six months after the operation. This state, however, recovered spontaneously to the euthyroid state within one year. Recurrent hyperthyroidism tends to increase with the lapse of years, while permanent hypothyroidism developed during the first or second year after operation. Results of our investigation suggest that the size of the remnant thyroid appears to play the most important role for an expected long term remission, and the optimal weight of the remnant thyroid should be approximately 10 grams. Although the precise mechanism of remission by surgical ablation of the thyroid has not been clarified, surgical treatment is an effective and safe procedure which controls the condition of the patient with thyrotoxicosis.

摘要

对447例行甲状腺次全切除术的患者进行了随访调查。本研究观察了433例患者,随访期为1年至10年。术后复发和甲状腺功能减退的发生率分别为9.6%和2.3%。大多数患者在术后3至6个月内出现短暂性亚临床甲状腺功能减退。然而,这种状态在1年内会自发恢复到甲状腺功能正常状态。复发性甲状腺功能亢进症倾向于随着时间的推移而增加,而永久性甲状腺功能减退症则在术后第一年或第二年出现。我们的调查结果表明,残余甲状腺的大小似乎对预期的长期缓解起着最重要的作用,残余甲状腺的最佳重量应约为10克。虽然通过手术切除甲状腺实现缓解的确切机制尚未阐明,但手术治疗是一种有效且安全的方法,可控制甲状腺毒症患者的病情。

相似文献

1
An evaluation of several prognostic factors in the surgical treatment for thyrotoxicosis.甲状腺毒症外科治疗中若干预后因素的评估
Surg Gynecol Obstet. 1981 May;152(5):639-41.
2
Surgical treatment of hyperthyroidism in children.儿童甲状腺功能亢进症的外科治疗
Surg Gynecol Obstet. 1977 Sep;145(3):343-6.
3
The importance of elevated TSH in serum after subtotal thyroidectomy for hyperthyroidism. A five-year follow-up study.甲状腺次全切除术后血清促甲状腺激素升高对甲亢的重要性:一项五年随访研究
Acta Chir Scand. 1981;147(8):645-7.
4
Clinical evaluation of the response to surgical treatment of Graves' disease.格雷夫斯病手术治疗反应的临床评估
Surg Gynecol Obstet. 1990 Apr;170(4):327-30.
5
Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.Graves病甲状腺次全切除术后很长时间甲状腺功能和免疫参数的变化
Eur J Surg. 1998 Mar;164(3):173-8. doi: 10.1080/110241598750004607.
6
[Postoperative course and tactics of aftercare in hyperthyroidism].[甲状腺功能亢进症的术后病程及术后护理策略]
Chirurg. 1984 Mar;55(3):171-3.
7
Long-term follow-up study of radioiodine treatment of hyperthyroidism.放射性碘治疗甲状腺功能亢进症的长期随访研究
Clin Endocrinol (Oxf). 2004 Nov;61(5):641-8. doi: 10.1111/j.1365-2265.2004.02152.x.
8
[Clinical evaluation of surgical treatment of Graves' disease].
Nihon Geka Gakkai Zasshi. 1989 Mar;90(3):423-8.
9
Postoperative endocrine function in patients with surgically treated thyrotoxicosis.手术治疗甲状腺毒症患者的术后内分泌功能
Head Neck. 2004 Apr;26(4):331-7. doi: 10.1002/hed.10389.
10
Long term follow-up of treated hyperthyroid and hypothyroid patients.
Health Bull (Edinb). 1993 May;51(3):177-83.

引用本文的文献

1
Subtotal thyroidectomy: a reliable method to achieve euthyroidism in Graves' disease. Prognostic factors.甲状腺次全切除术:一种使格雷夫斯病实现甲状腺功能正常的可靠方法。预后因素。
World J Surg. 2006 Nov;30(11):1950-6. doi: 10.1007/s00268-005-0770-x.
2
The outcome of patients with thyroid carcinoma and Graves' disease.
Surg Today. 1993;23(1):9-12. doi: 10.1007/BF00308993.
3
Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.甲状腺次全切除术治疗Graves病患者的随访评估及术后甲状腺功能障碍的危险因素分析
J Endocrinol Invest. 1993 Mar;16(3):195-9. doi: 10.1007/BF03344945.
4
A comparative evaluation of the surgical and radioiodine treatments for Graves' disease.格雷夫斯病手术治疗与放射性碘治疗的比较评估
Jpn J Surg. 1989 Jan;19(1):29-37. doi: 10.1007/BF02471563.
5
Thyroidectomy for Graves' disease: is hypothyroidism inevitable?甲状腺切除术治疗格雷夫斯病:甲状腺功能减退是否不可避免?
Ann R Coll Surg Engl. 1989 Mar;71(2):87-91.
6
Clinical and immunological studies on patients with Graves' disease preoperatively treated with corticosteroids and iodides.对术前接受皮质类固醇和碘化物治疗的格雷夫斯病患者的临床和免疫学研究。
Jpn J Surg. 1990 May;20(3):283-9. doi: 10.1007/BF02470662.